United KingdomHealthcare and life sciences2024 – ongoing

NHS Grampian, University of Aberdeen and Kheiron Medical Technologies

Mia AI in breast cancer screening

Mia AI found 12% more breast cancers than routine screening in a 10,889-patient UK evaluation

WorkingVendor's case studyVendor ↗

Problem

Mammogram screening misses about 20% of breast cancers, and the UK screens more than two million women a year. Radiologist workload is heavy.

Approach

NHS Grampian ran the first UK prospective evaluation of Kheiron's Mia alongside routine screening, with the University of Aberdeen. Microsoft hosted the tool on Azure, and the UK Government's AI in Health and Care Award funded the work. A simulated AI-assisted workflow was used to model workload.

Results

12%additional cancers found compared with routine practice, among 10,889 patientsVendor's case study[1]

up to 30%modelled (expected) reduction in screening workload from a simulated AI-augmented workflowVendor's case study[1]

Takeaway

Using Mia alongside routine screening increased cancer detection by 12% in the evaluation. The workload reduction of up to 30% was a model estimate.

Sources

12% more breast cancers detected, with potential workload savings of 30%, in the UK's first prospective evaluation of breast screening AI
Microsoft UK Stories21 Mar 2024Vendor publication

Source summaries

[1]Microsoft UK Stories21 Mar 2024

Microsoft reports the NHS Grampian evaluation of Kheiron's Mia tool on 10,889 patients. It gives the detection gain, the modelled workload saving and the finding of no rise in false recalls.

Full details are in the original sources.

Added 25 Oct 2026 · Updated 25 Oct 2026